Skip to main content
Verona Pharma plc (VRNA)
NASDAQ: VRNA · Real-Time Price · USD
38.92
-0.19 (-0.49%)
Dec 3, 2024, 1:54 PM EST - Market open

Verona Pharma Revenue

Verona Pharma had revenue of $5.62M in the quarter ending September 30, 2024. This brings the company's revenue in the last twelve months to $5.62M, up 1,127.95% year-over-year.

Revenue (ttm)
$5.62M
Revenue Growth
+1,127.95%
P/S Ratio
n/a
Revenue / Employee
$71,190
Employees
79
Market Cap
3.18B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023---
Dec 31, 2022458.00K-39.54M-98.86%
Dec 31, 202140.00M--
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
BrightSpring Health Services 10.59B
Surgery Partners 2.99B
Veracyte 425.33M
Kymera Therapeutics 87.56M
Merus 35.93M
Agios Pharmaceuticals 32.87M
Arrowhead Pharmaceuticals 3.55M
Revenue Rankings

VRNA News

More News